Harbor Advisory Corp MA Reduces Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Harbor Advisory Corp MA lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 31,525 shares of the exchange traded fund’s stock after selling 145 shares during the quarter. Harbor Advisory Corp MA’s holdings in SPDR S&P Biotech ETF were worth $3,115,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. ORG Partners LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at about $40,000. ORG Wealth Partners LLC purchased a new position in SPDR S&P Biotech ETF during the third quarter worth about $44,000. Resources Management Corp CT ADV boosted its stake in SPDR S&P Biotech ETF by 30.3% during the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after buying an additional 138 shares during the period. Lynx Investment Advisory purchased a new position in SPDR S&P Biotech ETF during the second quarter worth about $58,000. Finally, GPS Wealth Strategies Group LLC boosted its stake in SPDR S&P Biotech ETF by 35.9% during the second quarter. GPS Wealth Strategies Group LLC now owns 674 shares of the exchange traded fund’s stock worth $63,000 after buying an additional 178 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.1 %

XBI stock traded down $0.05 during mid-day trading on Tuesday, hitting $98.10. 1,212,060 shares of the company were exchanged, compared to its average volume of 9,432,303. The firm has a market capitalization of $7.48 billion, a P/E ratio of 11.47 and a beta of 1.11. The business has a fifty day simple moving average of $99.08 and a 200-day simple moving average of $94.40. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.